Your browser doesn't support javascript.
loading
Comparison of intravascular ultrasound-guided with angiography-guided double kissing crush stenting for patients with complex coronary bifurcation lesions: Rationale and design of a prospective, randomized, and multicenter DKCRUSH VIII trial.
Ge, Zhen; Kan, Jing; Gao, Xiao-Fei; Kong, Xiang-Quan; Zuo, Guang-Feng; Ye, Fei; Tian, Nai-Liang; Lin, Song; Liu, Zhi-Zhong; Sun, Zhi-Qi; He, Peng-Cheng; Wei, Lin; Yang, Wei; He, Yu-Quan; Xue, Yu-Zeng; Wang, Lian-Min; Miao, Li-Fu; Pu, Jun; Sun, Ya-Wu; Nie, Shao-Ping; Tao, Jian-Hong; Wen, Shang-Yu; Yang, Qing; Su, Xi; Yao, Qi-Cheng; Huang, Yi-Jie; Xia, Yong; Shen, Fa-Rong; Qiu, Chun-Guang; Mao, You-Lin; Liu, Qiang; Hu, Xin-Qun; Du, Zhi-Min; Nie, Ru-Qiong; Han, Ya-Ling; Zhang, Jun-Jie; Chen, Shao-Liang.
Afiliação
  • Ge Z; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Kan J; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Gao XF; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Kong XQ; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zuo GF; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Ye F; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Tian NL; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Lin S; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Liu ZZ; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Sun ZQ; Division of Cardiology, Daqing Oilfield General Hospital, Daqing, China.
  • He PC; Division of Cardiology, Guangdong Provincial People's Hospital, Guangzhou, China.
  • Wei L; Division of Cardiology, Harbin First Hospital, Harbin, China.
  • Yang W; Division of Cardiology, The 4th Affiliated Hospital of Harbin Medical University, Harbin, China.
  • He YQ; Division of Cardiology, China-Japan Friendship Hospital, Changchun, China.
  • Xue YZ; Division of Cardiology, Liaocheng People's Hospital, Liaocheng, China.
  • Wang LM; Division of Cardiology, Mudanjiang Cardiovascular Hospital, Mudanjiang, China.
  • Miao LF; Division of Cardiology, Beijing Huaxin Hospital, the First Hospital of Tsinghua University, Beijing, China.
  • Pu J; Division of Cardiology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Sun YW; Division of Cardiology, Shanghai Fourth People's Hospital, Shanghai, China.
  • Nie SP; Division of Cardiology, Beijing Anzhen Hospital, Capital Medical Hospital, Beijing, China.
  • Tao JH; Division of Cardiology, Sichuan Province People's Hospital, Chengdu, China.
  • Wen SY; Division of Cardiology, Tianjin 4th People's Hospital, Tianjin, China.
  • Yang Q; Division of Cardiology, Tianjin Medical University General Hospital, Tianjin, China.
  • Su X; Division of Cardiology, Wuhan Asia heart Hospital, Wuhan, China.
  • Yao QC; Division of Cardiology, Shenzhen Hospital, The University of Hong Kong, Shenzhen, China.
  • Huang YJ; Division of Cardiology, XuZhou Central Hospital, Xuzhou, China.
  • Xia Y; Division of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Shen FR; Division of Cardiology, Zhejiang Greentown Cardiovascular Hospital, Zhejiang, China.
  • Qiu CG; Division of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Mao YL; Division of Cardiology, The 7th People's Hospital of Zhengzhou, Zhengzhou, China.
  • Liu Q; Division of Cardiology, Fuwai Hospital Chinese Academy of Medical Science, Shenzhen, China.
  • Hu XQ; Division of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Du ZM; Division of Cardiology, The First Affiliated Hospital of Zhongshan University, Guangzhou, China.
  • Nie RQ; Division of Cardiology, Sun Yat-Sen Memorial Hospital, Zhongshan University, Guangzhou, China.
  • Han YL; Division of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
  • Zhang JJ; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Chen SL; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: chmengx@126.com.
Am Heart J ; 234: 101-110, 2021 04.
Article em En | MEDLINE | ID: mdl-33465369
ABSTRACT

BACKGROUND:

Double kissing (DK) crush approach for patients with coronary bifurcation lesions, particularly localized at distal left main or lesions with increased complexity, is associated with significant reduction in clinical events when compared with provisional stenting. Recently, randomized clinical trial has demonstrated the net clinical benefits by intravascular ultrasound (IVUS)-guided implantation of drug-eluting stent in all-comers. However, the improvement in clinical outcome after DK crush treatment guided by IVUS over angiography guidance for patients with complex bifurcation lesions have never been studied in a randomized fashion. TRIAL

DESIGN:

DKCRUSH VIII study is a prospective, multicenter, randomized controlled trial designed to assess superiority of IVUS-guided vs angiography-guided DK crush stenting in patients with complex bifurcation lesions according to DEFINITION criteria. A total of 556 patients with complex bifurcation lesions will be randomly (11 of ratio) assigned to IVUS-guided or angiography-guided DK crush stenting group. The primary end point is the rate of 12-month target vessel failure, including cardiac death, target vessel myocardial infarction, or clinically driven target vessel revascularization. The secondary end points consist of the individual component of primary end point, all-cause death, myocardial infarction, and in-stent restenosis. The safety end point is the incidence of definite or probable stent thrombosis. An angiographic follow-up will be performed for all patients at 13 months and clinical follow-up will be continued annually until 3 years after the index procedure.

CONCLUSIONS:

DKCRUSH VIII trial is the first study designed to evaluate the differences in efficacy and safety between IVUS-guided and angiography-guided DK crush stenting in patients with complex true bifurcation lesions. This study will also provide IVUS-derived criteria to define optimal DK crush stenting for bifurcation lesions at higher complexity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiografia Coronária / Ultrassonografia de Intervenção / Doença das Coronárias / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angiografia Coronária / Ultrassonografia de Intervenção / Doença das Coronárias / Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am Heart J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China